News

Home page

全部分类

Peking University Medicine Declares Class 3 Tumor Raw Material Drugs No Domestic Enterprise Produces

Release Time：2014-11-20

The website of the State Administration of Food and Drug Administration (CFDA) shows that Peking University Medicine (quotation, consultation)(000788.SZ) has accepted the application of 3 types of clinical antitumor chemical drug gefitinib. At present, only the original research tablets are on sale in China, and no domestic enterprises produce gefitinib and related preparations.

Zhu Baoguo Medical Mengqi Oral Liquid Transformation of Raw Material Drug Integration Road Rugged

Peking University Medicine Declares Class 3 Tumor Raw Material Drugs No Domestic Enterprise Produces

Zhu Baoguo Medical Mengqi Oral Liquid Transformation of Raw Material Drug Integration Road Rugged

Related News

The signing and unveiling ceremony of the graduate practice base of Jiangsu University was held in Jiangsu Yongda Pharmaceutical Co., Ltd.

On the morning of October 24, 2016, the unveiling ceremony of "Jiangsu University Graduate Practice Base" was held in our company. Ouyang Zhen, vice president of the School of Pharmacy of Jiangsu University, Qi Xueyong, director of the Department of Pharmacy, Zhang Caide, chairman of Jiangsu Yongda Pharmaceutical Co., Ltd., Zhang Weijie, general manager, Ge Qing, Minister of Quality Assurance, and Shixiaoya attended the signing and unveiling ceremony.